The evaluation of different surgical interventions revealed that the two most utilized treatments, intravitreal tPA + SF6 and intravitreal tPA + SF6 + anti-VEGF, showed significant improvement in BCVA from post-hemorrhage to 1-month post-surgery. This evidence concerns the gene VEGFA and hemorrhage.